Cue Biopharma, Inc. (CUE)
NASDAQ·Healthcare·Biotechnology
$31.00
-2.02%
Mkt Cap $83.33M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$4.33
Range $2.00 – $7.00
Implied Upside
-86.0%
Consensus $4.33 vs current $31.00
NASDAQ·Healthcare·Biotechnology
$31.00
-2.02%
Mkt Cap $83.33M
No recent rating data.
Price Target (4 analysts)
$4.33
Range $2.00 – $7.00
-86.0%
Consensus $4.33 vs current $31.00